Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in Dr Reddy s Laboratories

SEC to discuss Dr Reddy's application for emergency use of Sputnik V vaccine

SEC to discuss Dr Reddy's application for emergency use of Sputnik V vaccine

Read More

Dr Reddy's initiates process for emergency use authorisation of Sputnik V

Dr Reddy's initiates process for emergency use authorisation of Sputnik V

Read More

Dr Reddy's posts Q3 profit of Rs 20 crore, revenues at Rs 4,930 crore

Dr Reddy's posts Q3 profit of Rs 20 crore, revenues at Rs 4,930 crore

Read More

Sputnik V meets primary endpoint of safety in phase 2 clinical trial in India

Sputnik V meets primary endpoint of safety in phase 2 clinical trial in India

Read More

NSE Lists ADRs At NSE IFSC In GIFT City

Participants holding depository accounts with either of the international central securities depository (Euroclear Bank, Clearstream) or Depository Trust Company (DTC) will be able to transact on these ADRs.

Read More

Sputnik V from Russia arrives in India for clinal trials

Sputnik V from Russia arrives in India for clinal trials

Read More

Dr Reddy's Lab submits revised protocol to DCGI to conduct phase 2,3 clinical trials of Russian COVID-19 vaccine

Dr Reddy's Lab submits revised protocol to DCGI to conduct phase 2,3 clinical trials of Russian COVID-19 vaccine

Read More

Dr Reddy's Joins Science Based Targets Initiative (Sbti), Sets 2030 GHG Emission Targets

The company has committed to reducing its scope one and two greenhouse gas (GHG) emissions by 55 per cent by 2030 from an FY 2017-18 base year

Read More

India Trials For Russia's 'Sputnik-V' Vaccine Could Start In Next Few Weeks - Executive

India, which has a population of more than 1.3 billion, is the world's second worst affected country by COVID-19 behind the United States.

Read More

Equity Indices Trade Higher, Pharma Stocks Rally

BSE S&P Sensex was up by 136 points or 0.35 per cent at 39,115 while the Nifty 50 moved up by 56 points or 0.48 per cent at 11,576.

Read More

Dr Reddy's, RDIF to supply 100 million doses of Sputnik V vaccine to India

Dr Reddy's, RDIF to supply 100 million doses of Sputnik V vaccine to India

Read More

Dr Reddy's Launches Redyx (Remdesivir) In India For COVID-19 Treatment

Remdesivir is approved by Drug Controller General of India (DCGI) for restricted emergency use in India for the treatment of Covid-19 patients hospitalised with severe symptoms.

Read More

Let's End Hepatitis: A great initiative

Let's End Hepatitis: A great initiative

Read More

Dr Reddy's Laboratories Launches COVID-19 Treatment Drug In India

Dr Reddy's said Avigan has been approved by the Drugs Controller General of India (DCGI) for the treatment of patients with mild to moderate COVID-19.

Read More